A company validating biomarkers for both the diagnosis and prognosis of TBI married to a Point of Care (PoC) platform to assist with triage and patient treatment and recovery programs.
We are currently actively engaged with the US military to accelerate the validation of the biomarker in a robust clinical setting and to prepare our case for FDA application.
The next phase is to marry the biomarker to a PoC; either handheld or wearable